Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1968-4-6
|
pubmed:language |
ger
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0033-832X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
6
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
159-75
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:4965971-Antineoplastic Agents,
pubmed-meshheading:4965971-Humans,
pubmed-meshheading:4965971-Neoplasms,
pubmed-meshheading:4965971-Radiation Injuries,
pubmed-meshheading:4965971-Radioisotope Teletherapy,
pubmed-meshheading:4965971-Radiotherapy,
pubmed-meshheading:4965971-Radiotherapy, High-Energy
|
pubmed:year |
1966
|
pubmed:articleTitle |
[Supplementary treatment and observation of the disease course during radiotherapy and cytostatic treatment].
|
pubmed:publicationType |
Journal Article,
Review
|